UK & Ireland Prostate Brachytherapy Conference 2021 With regret, we have cancelled plans to run the May 2021 Conference. The Newcastle team had hoped the deferred meeting would go ahead, but we are still faced with a hugely uncertain situation regarding COVID-19.




2018 Conference Sponsors


Thank you to the following companies who are sponsoring the 2017 conference.



BXTAccelyon LogoBXTAccelyon, the leading low dose rate (LDR) brachytherapy partner to hospitals and clinics worldwide, is proud to announce it has become the sole distribution partner outside North America for the PrecisionPoint™ Transperineal Access System, a new medical device that is set to revolutionise prostate biopsies.


BXTAccelyon has a strong commitment to offering the very best products and services to centres:


• Experts in time sensitive distribution and world class customer service support

• Established distribution network in all major international regions

• Strong commitment to Research & Development, Clinical support, Patient awareness and education


Our products

In developing and refining our product line, we have worked with leading hospitals and manufacturers to deliver a range that addresses day-to-day requirements without compromising clinical outcomes.


• PrecisionPoint™ Transperineal Access System

• AgX100® Seed - longer silver rod improves visibility on imaging (II/CT)

• Gold Fiducial markers

• Strands and loose seeds

• Pre-loaded kits

• webBXT - on-line seed ordering system

• IsoLoader® - tailored implants with strands built in theatre


For more information please contact John Alden, Commercial Director-Northern Europe on +44 (0) 7881 029140 / [email protected]


Visit their website for more information.



BD Logo

BARD is a leader in solutions focused on Disease State Management in three key areas: Vascular, Urology, and Oncology.


Bard is dedicated to LDR Brachytherapy, providing a wide range of solutions to suite all techniques. We are proud to manufacture our own seeds and products. This ensures that we have total control on quality and delivery.


Visit the BARD website or contact Paul Tulk for more information [email protected].


In December 2017, Bard merged with BD (Becton, Dickinson and Company) to create a new global partnership for the advancement of medical care

Eckert and Ziegler Bebig logo

Eckert & Ziegler BEBIG s.a. are a dedicated brachytherapy company, proudly providing a complete portfolio of products for LDR, HDR and Ophthalmic treatments.


Through on-time delivery, consistent high quality, flexible manufacturing processes and constant self-improvement, we strive to meet the needs of our customers and the expectations of our investors.


In November 2013 Eckert & Ziegler BEBIG acquired Mick Radio-Nuclear Instruments, Inc., the leading manufacturer of applicators for brachytherapy, reinforcing our dedication and commitment to our business and your patients.


For more information please visit our company websites www.bebig.com and www.micknuclear.com

Elekta logoElekta Brachytherapy solutions are part of Elekta’s leading radiation therapy portfolio and encompass more than 35 years of Nucletron® innovations. This includes Esteya® electronic brachytherapy, Flexitron® afterloading, Oncentra® Brachy treatment planning, the broadest range of applicators in the industry and Real-time LDR/HDR Prostate Solutions

Visit their website for more information.


Augmenix logo

Augmenix, Inc. is a privately held company based in the Boston area and focused on the development and commercialization of radiation oncology products using its proprietary hydrogel technology. Focusing initially on protection during prostate radiation therapy, Augmenix next-generation products will address spacing and marking applications throughout the body to improve radiotherapy and interventional oncology procedure outcomes.


SpaceOAR® hydrogel, the company’s lead product, is a soft, absorbable gel spacer that pushes the rectum away from the prostate in men undergoing prostate radiotherapy, reducing rectal dose and injury to the rectum and surrounding tissues. SpaceOAR hydrogel, is cleared by the U.S. Food and Drug Administration (FDA) and has also received CE Mark approval in Europe, is approved in Australia and Japan, and is licensed in Canada. To date, over 17,000 patients worldwide have benefitted from the SpaceOAR hydrogel procedure.


More information about Augmenix and the SpaceOAR hydrogel can be found at www.Augmenix.com.

Bayer Healthcare logo

BAYER - Innovation for better health. At Bayer our commitment is to bring to patients around the world quality medicines for use in diagnosing, combating and preventing disease. Every day we work against time, researching new pathways, new molecules, new technologies – complementing our own capabilities with expertise of innovative partners from science and industry.


The success of this work is evidenced in new medicines for areas with significant unmet medical need such as oncology, cardiovascular and blood diseases, as well as gyneacology and ophthalmology. Our aim is a better quality of life for all.



MIM Software logo

MIM Software Inc. provides practical imaging solutions in the fields of radiation oncology, radiology, nuclear medicine, neuroimaging, and cardiac imaging. MIM offers solutions for PC and Mac® workstations, as well as mobile iOS and cloud-based platforms. MIM is a privately held company that sells its products globally to imaging centers, hospitals, specialty clinics, research organizations, and pharmaceutical companies.


MIM Symphony™ is an exciting new collaborative platform for prostate cancer diagnosis and management. With no compromise solutions for radiology and urology, both disciplines are able to focus on their specialties while providing each other a wealth of information for accurate diagnosis and staging.

Visit their website for more information.

Janssen logoThe Janssen Pharmaceutical Companies of Johnson & Johnson are dedicated to addressing and solving the most important unmet medical needs of our time. With over 100 years of scientific heritage, we actively focus on developing innovative treatments for patients in five important therapeutic areas of healthcare: oncology, neuroscience, infectious diseases, immunology and cardiovascular and metabolic diseases.


Driven by our commitment to patients, we develop sustainable, integrated healthcare solutions by working side-by-side with patient organisations, healthcare professionals and the NHS; based on partnerships of trust and transparency.


More information about Janssen-Cilag Limited can be found at: http://www.janssen.com/uk. Follow us on Twitter: @JanssenUK.

SeeDOS logoSeeDOS Ltd specializes in a range of Radiation Oncology, Urology and General Medical Equipment and Services. We are also dedicated to providing you with a professional, high quality, accurate, economic, reliable and timely prostate seed implant training and equipment supply, together with other related equipment and services, to assist you in the introduction or continuation of the prostate implant technique at your clinic.


Our new range of prostate biopsy products now include MultiCore Biopsy Needles designed to simplify the taking of multiple prostate biopsies for prostate biopsy mapping.


Visit www.seedos.co.uk for more information.

Varian LogoAs leaders in radiotherapy technology, Varian Medical Systems develop products supporting emerging oncology treatments. As a leader in brachytherapy technologies, Varian offers fully integrated, customizable treatment solutions for both planning and treatment delivery stages with:

  • Afterloaders

VariSource™ iX HDR afterloader and GammaMedplus™ iX HDR/PDR afterloader

  • Treatment planning software

BrachyVision™ brachytherapy treatment planning system, Acuros™ BV advanced dose calculation for brachytherapy, Vitesse™ real time planning for HDR brachytherapy, and VariSeed™ LDR prostate treatment planning system.

  • Applicators and accessories


Varian Medical Systems supports the following brachytherapy techniques:

  • HDR Brachytherapy
  • LDR Brachytherapy
  • PDR Brachytherapy
  • Image Guided Brachytherapy


For more information, please visit www.varian.com/brachytherapy


BK Ultrasound Small Logo

Analogic’s BK Medical ultrasound systems, incorporating Quantum Technology and TriCore architecture, offer unparalleled image quality with a range of specialized transducers including transducers dedicated to brachytherapy.


The newly introduced bk3000 system gives unrivalled image quality by using state of the art GPU’s to form the image, instead of the CPU’s that are normally used, this allows for reduced noise and artefacts, whilst increasing detail and contrast resolution at all depths.


This new introduction complements our Flex Focus system that is extremely mobile and flexible and allows up to 4 hours of plug-free imaging.


In addition we are now working with DK Technology to provide an MRI Fusion solution, where biopsies can be taken using either a transperineal ‘template’ or TRUS approach.


We have provided innovative ultrasound for over 30 years, improving patient care worldwide.


Visit www.bkmed.com for more information.

Oncology Imaging Systems Logo

Oncology Imaging Systems is a forward-thinking medical device company dedicated to providing the best products and the best customer service to the medical imaging, radiotherapy and medical physics communities. OIS specialises in patient positioning and immobilisation devices as well as radiation calibration and QA equipment for dosimetry, brachytherapy, intensity-modulated and image-guided radiotherapy, and stereotactic radiosurgery.


OIS is pleased to support the 2018 Prostate Brachytherapy UK & Ireland conference. We will be showcasing a range of products including our new innovative ProSpace prostate spacing balloon from BioProtect. The biodegradable device is designed to significantly reduce rectal dose, improve treatment planning options, and reduce long term toxicities enhancing the patients quality of life.


For sales enquiries, please contact: Mike Holroyd | 07967 111954 | [email protected] | www.oncologyimaging.com